SE8303925L - INTERFERON E - Google Patents

INTERFERON E

Info

Publication number
SE8303925L
SE8303925L SE8303925A SE8303925A SE8303925L SE 8303925 L SE8303925 L SE 8303925L SE 8303925 A SE8303925 A SE 8303925A SE 8303925 A SE8303925 A SE 8303925A SE 8303925 L SE8303925 L SE 8303925L
Authority
SE
Sweden
Prior art keywords
interferon
produced
new
human
cells
Prior art date
Application number
SE8303925A
Other languages
Unknown language ( )
Swedish (sv)
Other versions
SE8303925D0 (en
Inventor
Jr A P Jarvis
D I Kosowsky
Original Assignee
Damon Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Damon Biotech Inc filed Critical Damon Biotech Inc
Publication of SE8303925D0 publication Critical patent/SE8303925D0/en
Publication of SE8303925L publication Critical patent/SE8303925L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Disclosed is a new material having antiviral activity designated interferon epsilon. The material may be produced, for example, by exposing primary, diploid human eipthelial cells to a virus or certain nucleic acids and then incubating the cells under conditions in which the new interferon is produced and is secreted into the culture medium. The material produced by this process when assayed with cell cultures of human and bovine origin exhibits a unique profile of activity. The material also displays no significant cross reactivity with antisera prepared against either interferon alpha, interferon beta, or interferon gamma in neutralization assays.
SE8303925A 1982-07-12 1983-07-11 INTERFERON E SE8303925L (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US39761082A 1982-07-12 1982-07-12

Publications (2)

Publication Number Publication Date
SE8303925D0 SE8303925D0 (en) 1983-07-11
SE8303925L true SE8303925L (en) 1984-01-13

Family

ID=23571912

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8303925A SE8303925L (en) 1982-07-12 1983-07-11 INTERFERON E

Country Status (12)

Country Link
AU (1) AU573528B2 (en)
BE (1) BE897263A (en)
CH (1) CH664575A5 (en)
DE (1) DE3325131A1 (en)
DK (1) DK319883A (en)
FR (1) FR2531865A1 (en)
GB (1) GB2123835B (en)
IL (1) IL69205A0 (en)
IT (1) IT1203677B (en)
NL (1) NL8302484A (en)
NO (1) NO832517L (en)
SE (1) SE8303925L (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4614651A (en) * 1981-07-12 1986-09-30 Damon Biotech, Inc. Interferon epsilon
NL8401911A (en) * 1984-06-15 1986-01-02 Stichting Rega V Z W ANTI-VIRAL PROTEIN, METHOD FOR PRODUCING THE SAME, AND PHARMACEUTICAL PREPARATIONS CONTAINING THIS PROTEIN.
US4675282A (en) * 1984-07-06 1987-06-23 Damon Biotech, Inc. Assay for interferon epsilon
IL136326A0 (en) * 1997-12-08 2001-05-20 Genentech Inc Human interferon-epsilon: a type i interferon
ZA9811070B (en) 1997-12-08 2000-07-03 Genentech Inc Type I interferons.
IL142061A0 (en) * 1998-09-18 2002-03-10 Zymogenetics Inc Interferon-epsilon
CA2348157A1 (en) * 1998-12-01 2000-06-08 Genentech, Inc. Methods and compositions for inhibiting neoplastic cell growth
CN111420033A (en) * 2020-03-30 2020-07-17 温州肯恩大学(Wenzhou-KeanUniversity) Use of human interferon in tumor treatment

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4237224A (en) * 1974-11-04 1980-12-02 Board Of Trustees Of The Leland Stanford Jr. University Process for producing biologically functional molecular chimeras
US4016036A (en) * 1975-11-14 1977-04-05 Massachusetts Institute Of Technology Process for serially culturing keratinocytes
EP0014050A3 (en) * 1979-01-16 1980-10-01 Beecham Group Plc Interferon production
JPS56135420A (en) * 1980-03-26 1981-10-22 Fumiaki Taguchi Suppressive substance of virus and its preparation
JPS56167624A (en) * 1980-05-29 1981-12-23 Toray Ind Inc Method of interferon production

Also Published As

Publication number Publication date
SE8303925D0 (en) 1983-07-11
NL8302484A (en) 1984-02-01
CH664575A5 (en) 1988-03-15
AU1674883A (en) 1984-01-19
AU573528B2 (en) 1988-06-16
DE3325131C2 (en) 1987-08-13
DE3325131A1 (en) 1984-01-12
FR2531865A1 (en) 1984-02-24
DK319883D0 (en) 1983-07-11
BE897263A (en) 1983-11-03
GB8318726D0 (en) 1983-08-10
NO832517L (en) 1984-01-13
IT8367757A0 (en) 1983-07-12
IT1203677B (en) 1989-02-15
IL69205A0 (en) 1983-11-30
GB2123835B (en) 1986-06-18
DK319883A (en) 1984-01-13
GB2123835A (en) 1984-02-08

Similar Documents

Publication Publication Date Title
YU45871B (en) POLYPEPTIDE WITH HUMAN IMMUNOINTERFERON (IFN-GAMMA) PROPERTIES
DK95687A (en) PROCEDURE FOR CHARGING CULTIVATION OF ANIMAL CELLS
BR8105993A (en) MICROORGANISM CULTURE AND LIQUID COMPOSITION PROCESS
EP0200486A3 (en) Immobilization of biological cells in polytetrafluoroethylene matrix
SE8501534D0 (en) INTERFERON EPSILON
ATE234637T1 (en) IMPROVEMENTS IN OR RELATING TO ENDOMETRIAL FUNCTION
BR7803491A (en) PROCESS FOR THE PROMOTION OF FERMENTATION; AND FERMENTER
SE8303925D0 (en) INTERFERON E
ES480535A1 (en) Process for preparing human interferon.
ES2006714T3 (en) CELL CULTURE SUPPORTS, ETC.
ES8106552A1 (en) Process for propagating human hepatitis A virus in in vitro cell culture.
ATE15693T1 (en) CELL CULTURE PROCEDURE.
NZ183731A (en) Process for culturing cells(microorganism and tissue culture) dependent on the relationship between cycle time and biomass efficiency ratio
MX9273A (en) PROCEDURE FOR THE PREPARATION OF MONOCLONAL ANTIBODIES NEGATIVE ANTIGRAM AND CELL LINE WITH BIOLOGICAL ACTIVITY
GB2162198B (en) Process for producing dense nutrient medium for culturing microorganisms and macroorganism cell cultures
ATE41953T1 (en) INCREASED INHIBITION OF YEAST CELL GROWTH.
ES8300853A1 (en) Fixation of spherical microorganism cell
GB2016044A (en) Pretreatment of microcarriers for cell culture
EP0078061A3 (en) Method for culturing non-adhering mammalian cells
DK584486D0 (en) REACTOR FOR CULTURING BIOLOGICAL MATERIALS AS IMMOBILIZED CELLS
UA7845A1 (en) Solution for conservation of cell cultures
DE69014723D1 (en) Cell growth method.
DE3049825A1 (en) IMMOBILIZED ENZYME (S) AND MICROORGANISM (S) AND THEIR PRODUCTION
ES1003126U (en) Centering device supports urine cultures rectangular section (Machine-translation by Google Translate, not legally binding)
IT1233453B (en) PRODUCTION OF VINCAMIN AND EPIVINCAMIN BY MINOR VINCA CELL CULTURES.

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8303925-5

Effective date: 19881011

Format of ref document f/p: F